Cosmax Records Best Quarter as US Operations Turn Profitable

Record Performance Across Metrics

Cosmax reported consolidated revenue of 794.9 billion won ($560.8 million) for the April-June quarter, marking a 27 percent increase year-on-year, according to the company. Operating profit reached 73.7 billion won, up 21 percent from the same period last year. Both figures represent all-time highs for the Seoul-based contract manufacturer.

For the first half of 2026, total revenue stood at 1.48 trillion won, the company announced Tuesday.

US Market Breakthrough

The American operations delivered the sharpest growth among all geographic segments while crossing into profitability for the first time since Cosmax established its presence in the region. The milestone comes as Korean beauty brands and manufacturing partners accelerate their push into Western markets, where demand for K-beauty formulations and innovation continues to expand.

Contract manufacturing has become increasingly strategic for beauty brands seeking to scale production without building their own facilities. Cosmax operates as an original design manufacturer, handling everything from formulation development to packaging for clients that span indie brands and multinational corporations.

Regional Manufacturing Footprint

Cosmax maintains production facilities across Asia, including plants in South Korea, China, Indonesia, and Thailand. The company's business model centers on providing turnkey solutions for color cosmetics, skincare, and personal care products, allowing brands to bring products to market faster while controlling capital expenditure.

The second-quarter results underscore broader momentum in Asia's beauty supply chain, as manufacturers in the region capture a larger share of global production. South Korea in particular has emerged as a hub for cosmetics innovation, with companies like Cosmax, Kolmar Korea, and Cosmax NBT competing for contracts from brands in North America, Europe, and across Asia.

Market Context

The contract manufacturing sector has benefited from several tailwinds: the proliferation of digitally native beauty brands that lack manufacturing infrastructure, rising R&D costs that make outsourcing attractive, and consumer appetite for novel formulations that require specialized production capabilities.

Cosmax's performance also reflects the resilience of beauty spending even amid broader economic uncertainty. Premium and mass-market segments have both shown durability, with consumers continuing to allocate discretionary income toward skincare and cosmetics.

The company's ability to achieve profitability in the US market signals that its investment in local production capacity and client acquisition is beginning to pay off. American beauty brands have historically relied on domestic contract manufacturers, but Korean firms have gained traction by offering faster turnaround times, lower minimums, and expertise in trending categories like cushion compacts and essence-based skincare.

Looking Ahead

The first-half revenue of 1.48 trillion won positions Cosmax to potentially surpass 3 trillion won in annual revenue if momentum holds through the second half. The company has not issued formal guidance, but the trajectory suggests sustained demand across its key markets.

Investors and industry watchers will monitor whether the US business can sustain profitability as it scales, and whether competitive pressure from Chinese manufacturers intensifies. For now, Cosmax's ability to balance growth with margin expansion across multiple regions underscores the operational leverage inherent in its platform.